vimarsana.com

Page 2 - Kyle Mikson Cantor Fitzgerald News Today : Breaking News, Live Updates & Top Stories | Vimarsana

iCAD (ICAD) Q1 2021 Earnings Call Transcript

iCAD (ICAD) Q1 2021 Earnings Call Transcript
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.

Exagen Inc (XGN) Q4 2020 Earnings Call Transcript

Exagen Inc. (XGN) Q4 2020 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. Exagen Inc. (NASDAQ: XGN) Greetings, ladies and gentlemen, and welcome to the Exagen Inc. fourth-quarter 2020 earnings conference call. [Operator instructions] Please note that this conference is being recorded. I will now turn the conference over to our host, Mike Cavanaugh, investor relations for Exagen. Thank you. You may begin. Mike Cavanaugh Investor Relations Good afternoon, and thank you for joining us today. Earlier today, Exagen Inc. released financial results for the quarter and fiscal year ended December 31, 2020. The release is currently available on the company s website at www.exagen.com.

Pacific Biosciences of California (PACB) Q4 2020 Earnings Call Transcript

Operator Thank you for standing by, and welcome to the Pacific Biosciences of California, Inc. fourth-quarter 2020 earnings conference call. [Operator instructions] I would now like to hand the conference over to Trevin Rard. Please go ahead. Trevin Rard Investor Relations Thank you. Good afternoon, and welcome to the Pacific Biosciences fourth-quarter 2020 earnings conference call. We hope that you re keeping well during this time. Earlier today, we issued a press release outlining the financial results we ll be discussing on today s call, a copy of which is available on the Investors section of our website at www.pacb.com or, alternatively, as furnished on Form 8-K available on the Securities and Exchange Commission website at www.sec.gov.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.